Hydroquinone 4%, tretinoin 0.05%, fluocinolone acetonide 0.01%: a safe and efficacious 12-month treatment for melasma.
Year: 2005
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: Helen Mary Torok, Terry Jones, Phoebe Rich, Stacy Smith, Eduardo Tschen
Institutions: J&S Studies, Academic Dermatology Associates
Language: English
Subfield: Dermatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W16202972
